Usage: Gabapentin is indicated for managing postherpetic neuralgia in adults and as adjunctive therapy for partial onset seizures in adults and pediatric patients aged 3 years and older with epilepsy.
gabapentin
(Gabapentin)
Actavis Pharma, Inc.
Usage: Gabapentin capsules are indicated for managing postherpetic neuralgia in adults and as adjunctive therapy for partial onset seizures in adults and pediatric patients aged 3 years and older with epilepsy.
gabapentin
(Gabapentin)
ScieGen Pharmaceuticals, Inc.
Usage: Gabapentin is indicated for managing postherpetic neuralgia in adults and as adjunctive therapy for partial onset seizures in adults and pediatric patients aged 3 years and older with epilepsy.
gabapentin
(Gabapentin)
BioComp Pharma, Inc.
Usage: Gabapentin oral solution is indicated for managing postherpetic neuralgia in adults and as adjunctive therapy for partial onset seizures in adults and pediatric patients aged 3 and older with epilepsy.
keppra
(levetiracetam)
UCB, Inc.
Usage: KEPPRA is indicated for treating partial-onset seizures in patients aged 1 month and older. It is also approved as adjunctive therapy for myoclonic seizures in patients 12 years and older with juvenile myoclonic epilepsy and for primary generalized tonic-clonic seizures in patients 6 years and older with idiopathic generalized epilepsy.
lacosamide
(lacosamide)
Glenmark Pharmaceuticals Inc. USA
Usage: Lacosamide tablets are indicated for treating partial-onset seizures in patients aged 4 years and older. Additional pediatric usage information exists but is not included on the label due to marketing exclusivity rights.
lacosamide
(Lacosamide)
Zydus Pharmaceuticals USA Inc.
Usage: Lacosamide is indicated for the treatment of partial-onset seizures and as adjunctive therapy for primary generalized tonic-clonic seizures in patients aged 4 years and older.
lacosamide
(lacosamide)
Sintetica US LLC
Usage: Lacosamide Injection is indicated for the treatment of partial-onset seizures and as adjunctive therapy for primary generalized tonic-clonic seizures in patients aged 4 years and older.
lacosamide
(Lacosamide)
Zydus Pharmaceuticals USA Inc.
Usage: Lacosamide is indicated for treating partial-onset seizures in patients aged 4 and older and as adjunctive therapy for primary generalized tonic-clonic seizures in the same age group.
lamotrigine
(lamotrigine extended-release)
Yiling Pharmaceutical, Inc.
Usage: Lamotrigine Extended-Release Tablets are indicated for adjunctive therapy in patients aged 13 and older with primary generalized tonic-clonic seizures and partial-onset seizures. They can also be used for conversion to monotherapy in individuals with partial-onset seizures on a single antiepileptic drug. Safety is not established in patients under 13.